|
SLC25A12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.205000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.621200E-01 |
| Normal-vs-Stage2 |
9.902200E-01 |
| Normal-vs-Stage3 |
6.152000E-02 |
| Normal-vs-Stage4 |
1.390170E-01 |
| Stage1-vs-Stage2 |
7.113000E-01 |
| Stage1-vs-Stage3 |
3.121800E-02 |
| Stage1-vs-Stage4 |
2.416800E-01 |
| Stage2-vs-Stage3 |
1.843000E-01 |
| Stage2-vs-Stage4 |
3.995600E-01 |
| Stage3-vs-Stage4 |
7.958400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.570600E-01 |
| Normal-vs-AfricanAmerican |
2.913600E-01 |
| Normal-vs-Asian |
7.774400E-01 |
| Caucasian-vs-AfricanAmerican |
2.566200E-01 |
| Caucasian-vs-Asian |
6.947000E-01 |
| AfricanAmerican-vs-Asian |
9.282800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.044200E-01 |
| Normal-vs-Female |
1.977420E-01 |
| Male-vs-Female |
1.246610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.147010E-01 |
| Normal-vs-Extreme_Weight |
8.257400E-01 |
| Normal-vs-Obese |
9.000600E-01 |
| Normal-vs-Extreme_Obese |
3.130400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.125800E-01 |
| Normal_Weight-vs-Obese |
2.501800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.437180E-01 |
| Extreme_Weight-vs-Obese |
9.590400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.840600E-01 |
| Obese-vs-Extreme_Obese |
2.146600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.731200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.825800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.753800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.862400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.454400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.929600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.493900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.641800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.912100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.558400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.626200E-02 |
| Normal-VS-Type2 PRCC |
8.996800E-03 |
| Normal-VS-KIRP CIMP |
6.644400E-03 |
| Normal-VS-Unclassified PRCC |
2.170400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.30409999999659E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.060000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.700400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.468600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.208350E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.955500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.803440E-01 |
| Normal-vs-N1 |
2.590200E-01 |
| Normal-vs-N2 |
4.310500E-02 |
| N0-vs-N1 |
7.386400E-01 |
| N0-vs-N2 |
6.317700E-02 |
| N1-vs-N2 |
3.515800E-01 |
|
|
